Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients
TBIDU
Prevalence of Latent Tuberculosis and Enhanced Tuberculosis Case Detection Among Injecting Drug Users Receiving Methadone Substitution Treatment
1 other identifier
interventional
112
1 country
1
Brief Summary
The purpose of this study was to determine the prevalence of latent tuberculosis infection among injecting drug users and to conduct randomized controlled trial to evaluate a case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program in Estonia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2007
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 3, 2011
CompletedFirst Posted
Study publicly available on registry
February 4, 2011
CompletedFebruary 4, 2011
January 1, 2008
3 months
February 3, 2011
February 3, 2011
Conditions
Keywords
Study Arms (2)
Active referral
ACTIVE COMPARATORCase management intervention group - study personnel scheduled the TB doctor appointment for the participant, reminded to keep it, and transportation to the clinic was organized when needed.
Passive referral
NO INTERVENTIONParticipants were instructed to schedule an appointment with TB services themselves.
Interventions
Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program
Eligibility Criteria
You may qualify if:
- Participation in substitution treatment program,
- Age 18 years or more,
- Able to read and write in Estonian or Russian,
- Able to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LLC Corrigo
Jõhvi, Ida-Virumaa, 41532, Estonia
Related Publications (1)
Ruutel K, Loit HM, Sepp T, Kliiman K, McNutt LA, Uuskula A. Enhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trial. BMC Res Notes. 2011 Jun 15;4:192. doi: 10.1186/1756-0500-4-192.
PMID: 21676222DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
February 3, 2011
First Posted
February 4, 2011
Study Start
October 1, 2007
Primary Completion
January 1, 2008
Study Completion
January 1, 2008
Last Updated
February 4, 2011
Record last verified: 2008-01